These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6810185)

  • 1. Organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin.
    Rees S; Constantopoulos G; Barranger JA; Brady RO
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):262-70. PubMed ID: 6810185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suramin-treated rat as a model of mucopolysaccharidosis: reversibility of biochemical and morphological changes in the liver.
    Rees S; Constantopoulos G; Brady R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):235-45. PubMed ID: 2874656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suramin-treated rat as a model of mucopolysaccharidosis. Variation in the reversibility of biochemical and morphological changes among different organs.
    Rees S; Constantopoulos G; Brady RO
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):259-72. PubMed ID: 2879381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3700-4. PubMed ID: 6774343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin-induced storage disease. Mucopolysaccharidosis.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Am J Pathol; 1983 Nov; 113(2):266-8. PubMed ID: 6416076
    [No Abstract]   [Full Text] [Related]  

  • 6. Suramin-induced mucopolysaccharidosis in rat incisor.
    Gritli A; Septier D; Goldberg M
    Cell Tissue Res; 1993 Jul; 273(1):53-64. PubMed ID: 8364961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the alcianophilia of the drug suramin used as a tool for inducing experimental mucopolysaccharidosis.
    Christensen B; Lüllmann-Rauch R
    Histochemistry; 1988; 89(4):365-7. PubMed ID: 2457568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lysosomal storage diseases, genetic or drug-induced? effect of glycosaminoglycan and sphingolipid disorders on dental tissues].
    Goldberg M; Gritli A; Bloch-Zupan A; Septier D; Lécolle S; Legrand JM; Ruch JV
    C R Seances Soc Biol Fil; 1993; 187(5):596-607. PubMed ID: 8069712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute toxicity and bio-distribution of silver nitrate and nano-silver with different particle diameters in rats].
    Li TZ; Gong F; Zhang BY; Sun JD; Zhang T; Kong L; Xue YY; Tang M
    Zhonghua Shao Shang Za Zhi; 2016 Oct; 32(10):606-612. PubMed ID: 27765092
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphological and enzymatic heterogeneity of suramin-induced lysosomal storage disease in some tissues of mice and rats.
    Marjomäki V; Salminen A
    Exp Mol Pathol; 1986 Aug; 45(1):76-83. PubMed ID: 2875899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of mucopolysaccharidosis in rats by treatment with immunostimulatory acridine derivatives.
    Grave S; Lüllmann H; Lüllmann-Rauch R; Osterkamp G; Prokopek M
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):215-24. PubMed ID: 1609413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological studies on suramin toxicity in a chimpanzee.
    Gibson DW; Duke BO; Connor DH
    Tropenmed Parasitol; 1977 Sep; 28(3):387-405. PubMed ID: 910288
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of suramin on the activities of degradative enzymes of sphingolipids in rats.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):87-97. PubMed ID: 7291729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice.
    Vogler C; Birkenmeier EH; Sly WS; Levy B; Pegors C; Kyle JW; Beamer WG
    Am J Pathol; 1990 Jan; 136(1):207-17. PubMed ID: 2105058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tilorone-induced mucopolysaccharidosis in rats. Biochemical investigations.
    Prokopek M
    Biochem Pharmacol; 1991 Nov; 42(11):2187-91. PubMed ID: 1720315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
    Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in organs of rats in early stage after polytrauma combined with shock.
    Guan J; Jin DD; Jin LJ; Lu Q
    J Trauma; 2002 Jan; 52(1):104-11. PubMed ID: 11791059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver, lung, kidney, heart and spleen structure of rats after multiple intravenous injections of magnetite nanosuspension].
    Mil'go IV; Sukhodolo IV
    Vestn Ross Akad Med Nauk; 2012; (3):75-9. PubMed ID: 22712279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of [14C]suramin in tissues of male rats following a single intravenous dose.
    McNally WP; DeHart PD; Lathia C; Whitfield LR
    Life Sci; 2000 Sep; 67(15):1847-57. PubMed ID: 11043607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.